SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating OptiNose, Inc. Buyout

Wilmington, Delaware--(Newsfile Corp. - March 20, 2025) - Rigrodsky Law, P.A. is investigating OptiNose, Inc. ("OptiNose") (NASDAQ: OPTN) regarding possible breaches of fiduciary duties and other violations of law related to OptiNose's agreement to be acquired by Paratek Pharmaceuticals. Under the terms of the agreement, OptiNose shareholders will receive $9.00 per share in cash plus up to $5.00 per share in contingent value rights payable in the event that certain net revenue milestones are achieved.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-optinose-inc.

To contact Seth D. Rigrodsky or Gina M. Serra cost free, call (302) 295-5310 or email [email protected].

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/245492

You May Also Be Interested In

• Electra Therapeutics files for proposed IPO
• Lobe Sciences upsizes private placement to $2.16M
• Boeing secures $3B revolving credit facility, amends existing agreements